ArkeaBio is a global agricultural bioscience company developing a safe, cost-effective vaccine to reduce methane emissions from cattle all over the world. We are the first to successfully demonstrate a proof-of-concept vaccine. It’s the safest, most cost-effective solution for reducing greenhouse gas emissions in agriculture, and it’s the only one that can be quickly and sustainably scaled to reach all the world’s cattle. It’s a singular, scalable solution that delivers value to farmers, brands, consumers and our climate.
| Website | http://www.arkeabio.com |
| Employees | 37 (34 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Sustainable Agriculture, Methane Mitigation, Greenhouse Gas Reduction, Vaccine Technology, Carbon Footprint Reduction, Emission Control, Agritech, Climate Change Solutions, Agricultural Biotechnology, Agricultural Innovation, Animal Health, Precision Livestock Farming, Environmental Sustainability, Food Sustainability, Ruminant Health, Renewable Energy, Clean Energy Solutions |
| Competitors | Roche, Bayer, Amgen, Illumina, DuPont, Syngenta, Novozymes, Zymergen, Inc., Element Biosciences, Geno +39 more (view full list) |
Looking for a particular ArkeaBio™ employee's phone or email?
Frank Wooten is the CEO of ArkeaBio™.
34 people are employed at ArkeaBio™.